-

Sun Nuclear Announces Completion of Transition to CE Class IIb EU MDR Certification for Key Quality Management Solutions

SunCHECK® Software, SRS MapCHECK® and SunSCAN™ 3D Devices

Among 15+ Solutions Awarded New Certification

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, announced today that its SunCHECK® Quality Management software and key radiation therapy Quality Assurance (QA) devices have been awarded CE Class IIb certification under the European Medical Devices Regulation 2017/745 (EU MDR). The transition to EU MDR Class IIb recognizes the safety and performance of Sun Nuclear solutions and confirms compliance with stringent safety requirements.

Sun Nuclear solutions awarded Class IIb certification include:

  • The SunCHECK® Platform, a comprehensive software application facilitating essential Patient and Machine QA workflows and centralized data management;
  • Patient-specific QA solutions, including the ArcCHECK®, ArcCHECK®-MR, MapCHECK® 3 and SRS MapCHECK® devices, for measurement of radiation dose distributions against planned doses;
  • Machine QA solutions, including the Daily QA™ 3, Daily QA™ 3-MR, IC PROFILER™, IC PROFILER™-MR devices, for routine QA of linear accelerators used in treatment delivery; and
  • Beam Dosimetry, Scanning and Commissioning solutions, including: the 1D SCANNER™ and SunSCAN 3D™ water tanks; the PC Electrometer™ for absolute dose calibration and EDGE™ Detector for small-field beam modeling; and SNC125c™, SNC350p™ and SNC600c™ reference ion chambers.

“For 40 years, Sun Nuclear devices and software have helped radiation oncology and medical physics teams confidently adopt new technologies and techniques, enhance workflows, and improve patient care,” said Luis Rivera, president of Sun Nuclear and executive vice president of Mirion Medical. “The transition to Class IIb EU MDR certification reinforces our commitment to safe, efficient, and effective cancer treatment globally, and further positions the company for ongoing success in Europe.”

The Sun Nuclear portfolio will be featured in booth #280 at ESTRO 2025, May 2-6, in Vienna, Austria. ESTRO 2025 is the annual congress for the European Society for Radiotherapy and Oncology and includes Europe’s largest industry exhibition in radiation oncology.

About Sun Nuclear

Sun Nuclear is part of Mirion Medical, a group of healthcare-focused brands within Mirion, providing innovative solutions for Radiation Therapy and Diagnostic Imaging. More than 6,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, Sun Nuclear aims to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. Learn more: sunnuclear.com.

Contacts

For investor inquiries:
Eric Linn, ir@mirion.com

For media inquiries:
Erin Schesny, media@mirion.com

Sun Nuclear



Contacts

For investor inquiries:
Eric Linn, ir@mirion.com

For media inquiries:
Erin Schesny, media@mirion.com

More News From Sun Nuclear

Sun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technical experts and clinical partners for interoperability with the company's new radiotherapy system, Accela. Unveiled at the annual ASTRO conference, Accela is the first software-driven delivery system engineered for NeoArc (Dynamic Modulated Arc Therapy, DMAT), a new treatment technique that accelerates how radia...

Sun Nuclear to Unveil New Innovations Aimed at Strengthening Clinical Confidence at ASTRO 2026

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, will bring next-generation innovations for next-level confidence to the ASTRO 2026 Annual Meeting, beginning Sunday, September 27, in Boston. At Booth 915, attendees will get a first look at new solutions for radiation therapy quality assurance (QA), alongside dedicated programming on smarter QA workflows and one of oncology's fastest-growing areas: radiopharmaceutical therapy.An Exclusive Look: A New Way to See Machine Hea...

Sun Nuclear to Showcase Next-Generation Innovations at AAPM & COMP 2026 Annual Meeting

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, announced today the featured innovations in quality assurance (QA) for machine oversight and adaptive radiotherapy, as well as AI-assisted treatment planning, to be shown at the 2026 AAPM & COMP Annual Meeting, July 19–21 in Vancouver. Centered on the theme of Next-Gen Innovations for Next-Level Physics, the Sun Nuclear exhibit reflects a focus on smart, practical tools that support medical physics teams to operate wit...
Back to Newsroom